ALX Oncology has won two FDA fast-track designations for its lead immuno-oncology drug. The Irish-American biotech picked up the speedy reviews for ALX148 as a first-line treatment for head and ...

The price trend for ALX Oncology Holdings Inc. (ALXO ... and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower ...

The FDA cleared the firm this week to begin a Phase I study of ALX2004 in EGFR-expressing solid tumors, which could start in a few months.

ALX Oncology, a Bay Area biotech firm currently running clinical trials for its anticancer therapy, announced Wednesday that it’s laying off about 30% of its staff. ALX shared the news in a ...

NATL, BGC, NPSNY, ALX and VEEV have been added to the Zacks Rank #1 (Strong Buy) List on April 3, 2025. ALX, AVGO and BNPQY made it to the Zacks Rank #1 (Strong Buy) income stocks list on April 3 ...

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for ...

Jefferies analyst Michael Yee upgraded ALX Oncology (ALXO) to Buy from Hold with a price target of $3, up from $2. The company hosted a research and development day with two leading key opinion ...

Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven brokerages that are covering the stock ...